Conditions: Type 2 Diabetes Mellitus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 68
Healthy volunteers: no

Brief summary:
The purpose of this study is to test the effect MK-0941 as add-on therapy for adults taking insulin for Type 2 Diabetes.

Detailed description:

Arms:
arm 1: Participants receiving placebo tablets three times daily plus insulin injection once daily arm 2: Participants receiving MK-0941 tablets three times daily plus insulin injection once daily

Interventions: intervention 1: MK-0941 intervention 2: Placebo intervention 3: Insulin
Intervention descriptions: intervention 1: MK-0941 tablets 5 mg or 10 mg, taken 3 times daily, with increasing doses to maximally effective dose. intervention 2: Placebo tablets, taken 3 times daily. intervention 3: Insulin glargine (rDNA origin) injection solution for subcutaneous (SC) injection, taken once daily.

Protocol document: